Cornell scientists have discovered a potentially transformative approach to manufacturing one of the world's most widely used ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...